NAXOSPHARMA S R L has a total of 15 patent applications. Its first patent ever was published in 2003. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are ORIC PHARMACEUTICALS INC, ENDORECH and FRINCKE JAMES M.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 2 | |
#4 | New Zealand | 2 | |
#5 | United States | 2 | |
#6 | Canada | 1 | |
#7 | Italy | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Climate change adaptation technologies | |
#5 | Steroids |
# | Name | Total Patents |
---|---|---|
#1 | Lombardi Paolo | 15 |
#2 | Buzzetti Franco | 8 |
#3 | Arcamone Andrea Guido | 4 |
Publication | Filing date | Title |
---|---|---|
AU2010275640A1 | Benzoquinolizinium salt derivatives as anticancer agents | |
US2010099141A1 | Method and intermediates for preparing 2-alkoxy and 2-aryloxy estrogen compounds | |
WO2004106301A1 | Process for the synthesis of distamycin and derivatives thereof using 1-methyl-4-formylamino-2-pyrrolecarbonyl chloride iteratively as an intermediate | |
NZ544193A | Use of poly-aminopyrrolecarboxamides alone or in combination with a cyclodextrin in the prophylaxis and treatment of animal parasitosis |